Abstract
Effective multi-agent/multivalent vaccines that confer protection against more than one disease are highly desirable to the patient and to health-care professionals. Electroporation of DNA vaccines, whereby tissues injected with DNA are subjected to localized electrical currents, is an ideal platform technology that achieves protective immune responses to multivalent vaccination. Here, we describe an electroporation-based immunization technique capable of administering a cocktail of DNA vaccinations in vivo. Immune response measurements, including protection from pathogen challenge and induction of antigen-specific antibody responses and cell-mediated immune responses, are also discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
CDC (2000) Use of anthrax vaccine in the united states: recommendations of the advisory committee on immunization practices. MMWR 49:1–22
Feodorova VA, Corbel MJ (2009) Prospects for new plague vaccines. Expert Rev Vaccines 8:1721–1738
Meyer KF, Foster LE (1948) Measurement of protective serum antibodies in human volunteers inoculated with plague prophylactics. Stanford Med Bull 6:75–79
Vidor E (2007) The nature and consequences of intra- and inter-vaccine interference. J Comp Pathol 137(Suppl 1):S62–66
Johnston SA, Talaat AM, McGuire MJ (2002) Genetic immunization: what’s in a name? Arch Med Res 33:325–329
Robinson HL, Ginsberg HS, Davis HL, Johnston SA, Liu MA (1997) The scientific future of DNA for immunization. Am Acad Microbiol
Sardesai NY, Weiner DB (2011) Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 23:421–429
Donnelly J, Berry K, Ulmer JB (2003) Technical and regulatory hurdles for DNA vaccines. Int J Parasitol 33:457–467
Luxembourg A, Evans CF, Hannaman D (2007) Electroporation-based DNA immunisation: translation to the clinic. Expert Opin Biol Ther 7:1647–1664
Capone S, Zampaglione I, Vitelli A et al (2006) Modulation of the immune response induced by gene electrotransfer of a hepatitis c virus DNA vaccine in nonhuman primates. J Immunol 177:7462–7471
Dupuy LC, Richards MJ, Ellefsen B et al (2011) A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates. Clin Vaccine Immunol 18:707–716
Luckay A, Sidhu MK, Kjeken R et al (2007) Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81:5257–5269
Luxembourg A, Hannaman D, Ellefsen B, Nakamura G, Bernard R (2006) Enhancement of immune responses to an hbv DNA vaccine by electroporation. Vaccine 24:4490–4493
McCluskie MJ, Brazolot Millan CL, Gramzinski RA et al (1999) Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 5:287–300
Widera G, Austin M, Rabussay D et al (2000) Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164:4635–4640
Albrecht MT, Livingston BD, Pesce JT, Bell MG, Hannaman D, Keane-Myers AM (2012) Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague. Vaccine 30:4872–4883
McMahon JM, Wells DJ (2004) Electroporation for gene transfer to skeletal muscles: current status. BioDrugs 18:155–165
Yuan TF (2008) Vaccine submission with muscle electroporation. Vaccine 26:1805–1806
Kutzler MA, Weiner DB (2008) DNA vaccines: ready for prime time? Nat Rev Genet 9:776–788
Braun S (2008) Muscular gene transfer using nonviral vectors. Curr Gene Ther 8:391–405
Albrecht MT, Li H, Williamson ED et al (2007) Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against bacillus anthracis infection and enhance endogenous immunity to anthrax. Infect Immun 75:5425–5433
Williams JA, Carnes AE, Hodgson CP (2009) Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production. Biotechnol Adv 27:353–370
Marin M (2008) Folding at the rhythm of the rare codon beat. Biotechnol J 3:1047–1057
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Keane-Myers, A.M., Bell, M., Hannaman, D., Albrecht, M. (2014). DNA Electroporation of Multi-agent Vaccines Conferring Protection Against Select Agent Challenge: TriGrid Delivery System. In: Li, S., Cutrera, J., Heller, R., Teissie, J. (eds) Electroporation Protocols. Methods in Molecular Biology, vol 1121. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9632-8_29
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9632-8_29
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9631-1
Online ISBN: 978-1-4614-9632-8
eBook Packages: Springer Protocols